Skip to main content
Signal8

Gallagher Kathleen P.

SEC insider (Form 3/4/5 filer). CIK 0002048409. Director at Atrium Therapeutics, Inc. (RNA) and 1 other issuer. 25 reported Form 4/5 transactions since Sep 2024; latest on Sep 18, 2026. Located in SAN DIEGO, CA.

Companies Gallagher Kathleen P. has filed insider reports for

  • Atrium Therapeutics, Inc. (RNA): Director, Officer, See Remarks
  • Avidity Biosciences, Inc. (RNAM): Officer, Chief Program Officer
Gallagher Kathleen P. profile photo

Gallagher Kathleen P.

CIK: 0002048409

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)12 (48.0%)

Position reduction

Option Exercises (M)6 (24.0%)

Derivative conversions

Awards (A)3 (12.0%)

Compensation grants

Other (G, F, J, C, D, …)4 (16.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

Atrium Therapeutics, Inc. logo
RNA

Atrium Therapeutics, Inc.

DirectorOfficer
Avidity Biosciences, Inc. logo
RNAM

Avidity Biosciences, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (25 total)

  • Atrium Therapeutics, Inc. logo
    RNA

    Atrium Therapeutics, Inc.

    Sep 18, 2026
    Tax Payment
    Direct
    11.6K shares at avg. $8.95$104K
  • Atrium Therapeutics, Inc. logo
    RNA

    Atrium Therapeutics, Inc.

    Apr 20, 2026
    Award
    Direct
    102.5K shares-
  • Avidity Biosciences, Inc. logo
    RNAM

    Avidity Biosciences, Inc.

    Feb 27, 2026
    Disposition
    Direct
    80.3K shares-
  • Avidity Biosciences, Inc. logo
    RNA

    Avidity Biosciences, Inc.

    Dec 17, 2025
    Award
    Direct
    72K shares-
  • Avidity Biosciences, Inc. logo
    RNA

    Avidity Biosciences, Inc.

    Dec 17, 2025
    Tax Payment
    Direct
    8K shares at avg. $71.87$577K
  • Avidity Biosciences, Inc. logo
    RNA

    Avidity Biosciences, Inc.

    Dec 17, 2025
    Tax Payment
    Direct
    33.3K shares at avg. $71.87$2.4M
  • Avidity Biosciences, Inc. logo
    RNA

    Avidity Biosciences, Inc.

    Sep 2, 2025
    Sale
    Direct
    188 shares at avg. $47.42$9K
  • Avidity Biosciences, Inc. logo
    RNA

    Avidity Biosciences, Inc.

    Jun 17, 2025
    Sale
    Direct
    911 shares at avg. $30.24$28K
  • Avidity Biosciences, Inc. logo
    RNA

    Avidity Biosciences, Inc.

    Jun 2, 2025
    Exercise
    Direct
    5.9K shares at avg. $16.65$98K
  • Avidity Biosciences, Inc. logo
    RNA

    Avidity Biosciences, Inc.

    Jun 2, 2025
    Sale
    Direct
    5.9K shares at avg. $32.48$191K

1-10 of 25